![Xu Tian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Tian
Directeur/Membre du Conseil chez Beijing Shenogen Pharma Group Ltd.
Postes actifs de Xu Tian
Sociétés | Poste | Début | Fin |
---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/10/2019 | - |
Independent Dir/Board Member | 01/10/2019 | - |
Historique de carrière de Xu Tian
Formation de Xu Tian
China University of Political Science & Law | Graduate Degree |
Tarim University | Undergraduate Degree |
Statistiques
Internationale
Chine | 4 |
Opérationnelle
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Director/Board Member | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |